{"title":"generic (UK) Ltd (T/A Mylan)诉Warner-Lambert Company LLC","authors":"","doi":"10.1093/rpc/rcz005","DOIUrl":null,"url":null,"abstract":"\n Patents – Swiss-form claims – Pregabalin – Use in the manufacture or preparation of a medicament for the treating of pain – Construction – Validity – Infringement – Meaning of “for treating” neuropathic pain – Whether central neuropathic pain included – Insufficiency – Biogen insufficiency – Plausibility – Whether plausibility required across full width of claim – Nature of the plausibility requirement – Direct infringement under s.60(1)(b) – Whether intention a necessary element – Nature of the infringement test in relation to claims in Swiss form – Manufacturer liability – “Downstream” liability – Whether subjective intention required – Reasonable foreseeability – The role of packaging – Indirect infringement – Amendment – Post-trial validating amendments – Abuse of process – Discretion – Appeal to Supreme Court","PeriodicalId":336842,"journal":{"name":"Reports of Patent, Design and Trade Mark Cases","volume":"3 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Generics (UK) Ltd (T/A Mylan) v Warner-Lambert Company LLC\",\"authors\":\"\",\"doi\":\"10.1093/rpc/rcz005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n Patents – Swiss-form claims – Pregabalin – Use in the manufacture or preparation of a medicament for the treating of pain – Construction – Validity – Infringement – Meaning of “for treating” neuropathic pain – Whether central neuropathic pain included – Insufficiency – Biogen insufficiency – Plausibility – Whether plausibility required across full width of claim – Nature of the plausibility requirement – Direct infringement under s.60(1)(b) – Whether intention a necessary element – Nature of the infringement test in relation to claims in Swiss form – Manufacturer liability – “Downstream” liability – Whether subjective intention required – Reasonable foreseeability – The role of packaging – Indirect infringement – Amendment – Post-trial validating amendments – Abuse of process – Discretion – Appeal to Supreme Court\",\"PeriodicalId\":336842,\"journal\":{\"name\":\"Reports of Patent, Design and Trade Mark Cases\",\"volume\":\"3 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Reports of Patent, Design and Trade Mark Cases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/rpc/rcz005\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reports of Patent, Design and Trade Mark Cases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/rpc/rcz005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Generics (UK) Ltd (T/A Mylan) v Warner-Lambert Company LLC
Patents – Swiss-form claims – Pregabalin – Use in the manufacture or preparation of a medicament for the treating of pain – Construction – Validity – Infringement – Meaning of “for treating” neuropathic pain – Whether central neuropathic pain included – Insufficiency – Biogen insufficiency – Plausibility – Whether plausibility required across full width of claim – Nature of the plausibility requirement – Direct infringement under s.60(1)(b) – Whether intention a necessary element – Nature of the infringement test in relation to claims in Swiss form – Manufacturer liability – “Downstream” liability – Whether subjective intention required – Reasonable foreseeability – The role of packaging – Indirect infringement – Amendment – Post-trial validating amendments – Abuse of process – Discretion – Appeal to Supreme Court